XORTX Therapeutics Inc (TSE:XRTX) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
XORTX Therapeutics Inc. has successfully closed a $1.5 million registered direct offering and concurrent private placement. The company plans to use the proceeds for working capital and general corporate purposes. This financial maneuver reflects XORTX’s ongoing efforts to advance its innovative therapies for kidney disease.
For further insights into TSE:XRTX stock, check out TipRanks’ Stock Analysis page.
